Kaski, Juan Carlos

Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the Working Group for Cardiovascular Pharmacotherapy of the European Society of Cardiology

Schmidt, M., Lamberts, M., Olsen, A.-M. S., Fosbøll, E., Niessner, A., Tamargo, J., Rosano, G., Agewall, S., Kaski, J. C., Kjeldsen, K., et al. (2016) · European Heart Journal

Inflammatory mediators and NSAID effectsAntiplatelet Therapy and Cardiovascular Diseases

Cited by 164

Prognostic Value of Admission Myeloperoxidase Levels in Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock

Dominguez-Rodriguez, A., Samimi-Fard, S., Abreu-Gonzalez, P., Garcia-Gonzalez, M. J., & Kaski, J. C. (2008) · The American Journal of Cardiology

Acute Myocardial Infarction ResearchInflammatory Biomarkers in Disease Prognosis

Cited by 46

The Role of Microbiota in Cardiovascular Risk: Focus on Trimethylamine Oxide

Al-Rubaye, H., Perfetti, G., & Kaski, J.-C. (2019) · Current Problems in Cardiology

Gut microbiota and healthNutritional Studies and Diet

Cited by 43

Targeting T cells to treat atherosclerosis: odyssey from bench to bedside

Bullenkamp, J., Dinkla, S., Kaski, J. C., & Dumitriu, I. E. (2016) · European Heart Journal - Cardiovascular Pharmacotherapy

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 38